Clinical trials
Obesity clinical trials
Excess body weight that increases the risk of many other health conditions. We’re tracking 1,434 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07815067RecruitingPhase 1
Meal timing and water intake with Zenagamtide for overweight or obesity
This study tests how the timing of your meal and how much water you drink with the medicine affect how your body absorbs a new medicine called Zenagamtide. If you have overweight or obesity, this could help find the best way to take the medicine for maximum effect.
BerlinAges 18 years+ - NCT06124456Recruiting
Vigorous vs. moderate exercise for liver fat reduction
This study compares high-intensity exercise to moderate-intensity exercise to see which is better at reducing fat in the liver for people with obesity and fatty liver disease.
Hong KongAges 18–69 - NCT07810517Recruiting
Probiotic and fiber supplement for memory in obesity
This study tests a daily supplement (a probiotic called Lactobacillus acidophilus plus a fiber called inulin) to see if it might help improve memory and thinking in adults with long-term obesity and mild cognitive impairment. If you qualify, you would take the supplement or a placebo for a period of time while the study team monitors your cognitive function.
Huixquilucan, State of MexicoAges 30–40 - NCT07817069Recruiting
Nitraria retusa tea for weight issues caused by clozapine
This trial tests whether a tea made from the plant Nitraria retusa can help reduce the weight gain and metabolic side effects caused by the medication clozapine. If you take clozapine for schizophrenia and have gained weight, this tea might help you manage that side effect.
SousseAges 18–65 - NCT07811115Recruiting
Physical activity and heart health in teens with obesity
This study looks at how different levels of physical activity and sitting time relate to the thickness of the carotid artery (the main artery in the neck) in teenagers with obesity. This may help doctors understand how to better protect heart health in young people.
Palavas-les-FlotsAges 11–18 - NCT07808073RecruitingPhase 1
A weight-loss medicine study for people with overweight or obesity
This study tests an experimental medicine (LY4329090) to see if it can help people with overweight or obesity lose weight. You would be monitored closely for safety, and you may or may not receive the study drug.
Daytona Beach, FloridaAges 18–65 - NCT07803809RecruitingPhase 1
MWN105 injection for overweight and obesity
This study tests an investigational injection called MWN105 in people who are overweight or obese but do not have diabetes. The goal is to see if it is safe and helps with weight loss.
Kunming, YunnanAges 18–50 - NCT07803744RecruitingPhase 1
Study of tirzepatide for type 1 diabetes with overweight
This study tests a weekly injection called tirzepatide in people with type 1 diabetes who are overweight or have obesity. The goal is to see if it helps with blood sugar control and weight loss when added to insulin therapy.
Miami, FloridaAges 18–70 - NCT07808060RecruitingPhase 1
Study of an investigational weight-loss drug in women with overweight or obesity
This study tests an investigational medication called eloralintide to see if it helps with weight loss in women who are overweight or have obesity. Participants will receive the study drug and be monitored for safety and effectiveness.
Daytona Beach, FloridaAges 18–60 - NCT07802080Recruiting
Kettlebell and breathing exercises for lung health in overweight young adults
This study tests a 12-week program of kettlebell exercises combined with breathing exercises to see if it improves breathing muscle strength and lung function in young adults who are overweight or obese. If you are interested in improving your fitness, it may be a good option.
Phayao, Changwat PhayaoAges 18–25 - NCT07804290Enrolling by invitation
Recovery and satisfaction after metabolic surgery
This study looks at how well patients recover and how satisfied they are after metabolic surgery (weight-loss surgery) at a hospital in Gauteng, South Africa. It uses simple questionnaires to understand the patient experience.
Ga-Rankuwa, GautengAges 18 years+ - NCT07796503Recruiting
Comparing two ways to measure the bypass in weight-loss surgery
This study compares two methods for choosing the length of the intestinal bypass in a weight-loss surgery called one-anastomosis gastric bypass. It may help improve weight loss and reduce complications.
AlmatyAges 18–65 - NCT07793019RecruitingPhase 1
Weight loss and safety study in overweight adults
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Beijing, Beijing MunicipalityAges 18–55 - NCT07796971Recruiting
Exercise in low vs normal oxygen for weight and gut health
This study tests two exercise programs—one in low oxygen, one in normal oxygen—to see which is better at reducing body fat and improving gut health in adults aged 50–75 who are overweight or obese. You'll do high-intensity interval training (short bursts of intense exercise) and we'll monitor your results over time.
Bellerive-sur-AllierAges 50–75 - NCT07787468Enrolling by invitation
Videolaryngoscopes for airway management in severely obese patients
This study compares different videolaryngoscopes for airway management during bariatric surgery in people with severe obesity, aiming to improve safety and ease of intubation.
Radom, Masovian VoivodeshipAges 18 years+ - NCT07784725RecruitingPhase 3
Study of a weight loss injection for adults with obesity
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
Dothan, AlabamaAges 18 years+ - NCT07784270RecruitingPhase 3
Weight loss injection for adults with type 2 diabetes and overweight
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
Fairhope, AlabamaAges 18 years+ - NCT07776509RecruitingPhase 3
Adding a new drug to current weight-loss therapy for adults with obesity or overweight
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
Escondido, CaliforniaAges 18 years+ - NCT07776678Recruiting
Body fat and muscle measurement study
This study uses advanced body scans (like MRI and DXA) to better measure body fat and muscle. It may help improve how obesity is diagnosed and treated.
Phoenix, ArizonaAges 18 years+ - NCT07782281Recruiting
Early discharge with home care after weight-loss surgery
This study compares early discharge from the hospital with follow-up care at home versus the usual hospital stay after bariatric (weight-loss) surgery. It aims to see if going home early with home care is safe and reduces costs.
Sabadell, BarcelonaAges 18–65 - NCT05120492Recruiting
Program for severe knee arthritis and extreme weight
This feasibility study tests a practical approach to help people with very severe knee arthritis and very high body weight. It aims to find an effective and safe way to manage both conditions together in real-world care.
Halifax, Nova ScotiaAges 18–65 - NCT07775404RecruitingPhase 3
Weight loss medication for Asian adults with obesity or overweight
This study tests an investigational medication called elecoglipron for weight loss in Asian adults who are overweight or have obesity, with or without type 2 diabetes. It may help participants lose weight and improve health.
BaotouAges 18 years+ - NCT07767175RecruitingPhase 1
Weight loss study for adults with overweight or obesity
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
Lenexa, KansasAges 18–55 - NCT07768813RecruitingPhase 1
Comparing two versions of an injected drug in healthy and overweight people
This trial compares two different versions of an injected study drug (survodutide) to see how they are absorbed by the body. It is open to healthy people and people with overweight or obesity, and it may help researchers find a better way to deliver this treatment.
MannheimAges 18–55
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obesity?
- Yes. Clin2 currently lists 1,434 recruiting obesity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.